Histological and transcriptomic analyses confirmed NAFLD‐like pathology and inflammation, and our observation of gut microbiota dysbiosis with elevated TNF‐α and IL‐6 supports a mechanism involving increased intestinal permeability and translocation of pro‐inflammatory microbial products such as LPS. The gene discussed is IL6; the disease is metabolic dysfunction-associated steatotic liver disease.